fozivudine tidoxil has been researched along with HIV Coinfection in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anglaret, X; Danel, C; Eholie, S; Ello, F; Girard, PM; Hoelscher, M; Kroidl, A; Lennemann, T; Maganga, L; Mgaya, J; Moh, R; Pruvost, A; Saathoff, E; von Massow, F; Zuhse, R | 1 |
Anderson, R; Boerner, D; Diquet, B; Girard, PM; Pegram, PS; Raffi, F; Sereni, D; Tubiana, R | 1 |
Boerner, D; Bogner, JR; Goebel, FD; Herrmann, DB; Hoegl, L; Jost, V; Mühlhöfer, A; Roecken, M; Thoma-Greber, E | 1 |
Boerner, D; Bogner, JR; Goebel, FD; Gürtler, L; Herrmann, DB; Kaufmann, B; Plewig, G; Roecken, M | 1 |
1 review(s) available for fozivudine tidoxil and HIV Coinfection
Article | Year |
---|---|
Fozivudine: BM 211290, fozivudine tidoxil, FZT, HDP 990002, W 09726867.
Topics: Animals; Anti-HIV Agents; Drugs, Investigational; HIV Infections; Humans; Lipids; Zidovudine | 2004 |
4 trial(s) available for fozivudine tidoxil and HIV Coinfection
Article | Year |
---|---|
Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Cote d'Ivoire; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Lipids; Male; Middle Aged; Prospective Studies; Sustained Virologic Response; Tanzania; Treatment Outcome; Zidovudine | 2017 |
Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy.
Topics: Adult; Anti-HIV Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load; Zidovudine | 2000 |
Single dose, dose-escalating trial with fozivudine tidoxil (BM 21.1290).
Topics: Adult; Anti-HIV Agents; Food; HIV Infections; Humans; Lipids; Male; Middle Aged; Zidovudine | 1997 |
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial.
Topics: Adult; Anti-HIV Agents; HIV Infections; Humans; Lipids; Male; Middle Aged; RNA, Viral; Zidovudine | 1997 |